Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Eligibility Criteria for Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

1 May 2020

Abstract excerpt

Eligibility assessment of a potential candidate for allogeneic hematopoietic cell transplantation (allo-HCT) is a complex yet vital component of pretransplant evaluation. Although no formal standardized consensus exists to guide this process, transplant centers follow institutional standard operating procedures and parameters to approve candidacy of an individual patient. Consideration for allo-HCT is dependent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Acute Myeloid Leukemia Research
Share to Hematopoietic Stem Cell Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32380457
DOI: 10.6004/jnccn.2020.7559

Provenance

PubMed metadata and Literature Corpus relationships.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Eligibility Criteria for Patients Undergoing Allogeneic Hematopoietic Cell TransplantationPMID 32380457Read ↗

Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I)Semantic proximity Read ↗

Frailty in Lung Transplantation: Candidate Assessment and Optimization.Semantic proximity Read ↗

Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Older Patients with Myelodysplastic SyndromesSemantic proximity Read ↗

How we approach patient evaluation for hematopoietic stem cell transplantationSemantic proximity Read ↗

Health‐related quality of life in reduced‐intensity hematopoietic cell transplantation based on donor availability in patients aged 50–75 with advanced myelodysplastic syndrome: BMT CTN 1102Semantic proximity Read ↗

Comorbidities and Hematopoietic Cell Transplantation OutcomesSemantic proximity Read ↗

Impact of a Nutritional Risk Index on Clinical Outcomes after Allogeneic Hematopoietic Cell TransplantationSemantic proximity Read ↗

Biobanks and registries for HSCT research: potential for future individualized medicine.Semantic proximity Read ↗

Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study.Semantic proximity Read ↗

Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group ReportSemantic proximity Read ↗

Allogeneic hematopoietic stem cell donation—standardized assessment of donor outcome data: A consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)Semantic proximity Read ↗

Allogeneic haemopoietic stem cell transplantation in children: what alternative donor should we choose when no matched sibling is available?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.